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by Elsevier B.V. This is an open accesAbstract Background: Inflammatory bowel disease (IBD) includes Crohn’s disease (CD), ul-
cerative colitis (UC), and indeterminate colitis (IC). IBD is a disorder characterized by chronic
inflammation of the gastrointestinal tract with frequent relapse and remission courses. There
is limited information regarding this disease in Saudi children, despite a rising worldwide inci-
dence of IBD.
Objective: To study clinical and demographic characteristics of Saudi children diagnosed with
IBD at time of presentation. Diagnosis, disease localization, and growth of pediatric IBD pa-
tients were compared with international data.
Study design: In this retrospective study, charts of all children under the age of 14 years who
were diagnosed with IBD and received follow-up at King Faisal Specialist Hospital and Research
Center (KFSH&RC) from January 2001 to December 2011 were reviewed.
Results: Sixty-six children were diagnosed with IBD; 36 (54.5%) had Crohn’s disease (CD), 27
(41%) had ulcerative colitis (UC), and 3 (4.5%) had indeterminate colitis (IC). A male predom-
inance was demonstrated in both CD (61%) and UC (56.6%). The mean age at diagnosis was 9.3,
7.3 and 7.5 years in CD, UC and IC, respectively. A positive family history was found in 19.7% of
all patients. The most common presenting symptoms were diarrhea (89.4%), rectal bleeding
(75.8%) and abdominal pain (62%). The most common site affected in CD was the ileocolonic
region (41.6%) while pancolitis was predominant in UC (74.1%).Q2 Q3
.edu.sa, aabufaris@gmail.com (K. Alsaleem).
f King Faisal Specialist Hospital & Research Centre (General Organization), Saudi Arabia.
112
113
114
115
116
117
118
119
120
121
122
reheili K, et al., Clinical presentation of inflammatory bowel disease in Saudi children (Single centre
Pediatrics and Adolescent Medicine (2016), http://dx.doi.org/10.1016/j.ijpam.2016.08.004
16.08.004
al Specialist Hospital & Research Centre (General Organization), Saudi Arabia. Production and hosting
s article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Q4
2 K. Alreheili et al.
+ MODEL
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
IJPAM87_proof ■ 15 September 2016 ■ 2/5Table 1 Demographic character
Nationality
S
NS
Gender
M
F
Age range (years)
<2
2e<6
>6
Age range (years)
Mean (years)
Interval between diagnosis and pr
Range (months)
Mean (Months)
Family history of IBD
Total
64
65
66
67
68
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experience), International Journal oConclusions: CD is the most prevalent form of IBD in Saudi children. Male predominance and a
high rate of growth failure were documented in children with CD. Clinical presentation, family
history and disease localization are comparable to international data.
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1011. Introduction
Inflammatory bowel disease (IBD) includes Crohn’s disease
(CD), ulcerative colitis (UC), and indeterminate colitis.
These inflammatory conditions are induced by complex in-
teractions between environmental, genetic, microbial and
immunoregulatory factors. Their exact etiology remains
obscure.
Inflammatory bowel disease (IBD) is a disorder charac-
terized by chronic inflammation of the gastrointestinal
tract with frequent relapse and remission courses. The
diagnosis and differentiation of Crohn’s disease or ulcera-
tive colitis is based on clinical, radiographic, endoscopic,
and histological findings [14e16].
Observations of children with IBD often suggest a more
severe course than those found in adults [8,9]. As the
incidence of inflammatory bowel disease (IBD) is rising
worldwide [10e13], the data concerning this disease in
Saudi children is beginning to increase [1e7].
2. Method
In this retrospective study the charts of all children under
the age of 14 years who were diagnosed with IBD and
received follow-up in our hospital (King Faisal Specialist
Hospital and Research Center, Riyadh, Saudi Arabia) from
January 2001 to December 2011 were reviewed. This study
included 66 pediatric patients under 14 years of age at timeistics of inflammatory bowel di
CD
33 (92%)
3 (8%)
22 (61%)
14 (39%)
4 (11.1%)
1 (2.8%)
31 (86.1%)
(0.25e14)
9.3
esentation (1e36)
8.7
5 (14%)
36 (54.5%)
reheili K, et al., Clinical presentat
f Pediatrics and Adolescent Medicof diagnosis who were diagnosed with inflammatory bowel
disease as confirmed by clinical, endoscopic, radiologic and
histopathological evaluation. Variables analyzed included
patient demographics (age, gender, nationality and region),
clinical presentation, length of symptoms before diagnosis,
growth, family history, and diagnostic findings include
laboratory, radiological endoscopic and histopathological
findings. The data were analyzed and presented in a simple
percentage format.
3. Ethical consideration
This study is entitled Pediatric Inflammatory Bowel Disease
in Saudi Arabia with RAC # 2101090. The study was reviewed
by a research ethics committee (Research Advisory Council,
Office of Research Affairs) at KFSH&RC Riyadh on 20 October
2012 and the proposal was recommended for approval.
4. Results
Sixty-six patient were diagnosed with IBD from January
2001 to December 2011; 36 (54.5%) had CD, 27 (41%) had UC
and 3 (4.5%) had IC. Most of the patients included in the
study were Saudi (94%) (see Table 1).
Of 66 IBD patients, 38 (57.6%) were male and 28 (42.4%)
were female. The male-to-female ratio was 1.35. A male
predominance was demonstrated in both CD (61%) and UC
(56.6%).seases in Saudi children. Q10
UC IC Total (%)
26 (96.3%) 3 (100%) 62 (94%)
1 (3.7%) 0 4 (6%)
15 (55.6%) 1 (33.3%) 38 (57.6%)
12 (44.6%) 2 (66.7%) 28 (42.4%)
1 (3.7%) 5 (7.6%)
8 (29.6%) 9 (13.6%)
18 (66.7%) 3 (100%) 52 (78.8%)
(1.75e14) (6e9.5) (0.25d14)
7.6 7.5 8.1
(6e12)
(1e60)
8.4
6 (22.2%) 2 (66.7%) 13 (19.7%)
27 (41%) 3 (4.5%) 66 (100%)
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IJPAM87_proof ■ 15 September 2016 ■ 3/5The mean age at diagnosis (and range) was 8.1 y
(0.25e14) for IBD as a whole and 9.3 y (0.25e14), 7.6 y
(1.75e14) and 7.5 y (6e9.5) for CD, UC and IC, respectively.
Most patients presented at age 6 years or older as follows:
whole IBD, 52 (78.8%); CD, 31 (86.1%); UC, 18 (66.7%); IC 3
(100%). For children between the ages of 2 and less than 6,
the frequency of UC was higher with 8 (29.6%) children
diagnosed while CD was higher among under the age of 2
with 4 (11.1%) children diagnosed (Table 1). The mean of
interval from the onset of symptoms to diagnosis was 9
months (1e60) for IBD; 8.7 months (1e36) for CD; 8.4 m
(2e60) for UC and 10 m (6e12) for IC.
A family history of IBD was found in 19.7% of children
with IBD. This percentage was higher in UC patients; family
history was found in 22.2% of patients with UC whereas in
CD patients the family history was positive in 14%.
The most frequent presenting symptoms were diarrhea
(89.4%), rectal bleeding (75.8%), and abdominal pain (62%).
Diarrhea (89%) and abdominal pain (77.8%) were the most
common symptoms in CD, whereas bloody diarrhea was the
most frequent presenting symptom in UC (100%), see Table 2.
Other symptomswereweight loss [weight less than 5%] (50%),
growth failure [body mass index < 2SD] (37.9%), fever
(33.3%), anorexia (21%) and arthritis (10.6%). Perianal disease
in CD patients was observed as follows: anal fissure (33.3%);
skin tags (22.2%); anal fistula (16.7%); anal abscess (11.1%);
and anal ulcer (5.6%). Anal fissures and tags are the most
common perianal disease in UC patients. Skin manifestations
were found mainly in CD patients; these lesions include ery-
thema nodosum (8.3%) and aphthous lesions (14%).
Laboratory findings revealed that anemia and high ESR
were the most common findings; these were found in 51 pa-
tients (77.3%). Other findings were thrombocytosis in 46 pa-
tients (70%) and low albumen in 33 patients (50%) (see Fig. 1).Table 2 Clinical characteristics of Inflammatory bowel disease
CD
Common symptom Fever 15 (41.7
Abdominal pain 28 (77.8
Diarrhea 32 (89%)
Rectal bleeding 22 (61.1
Weight loss 25 (69.4
Growth failure 17 (47%)
Nausea/vomiting 12 (33.3
Other symptoms Fatigue 5 (14%)
Aphthous lesions 5 (14%)
Constipation 0
Hepatomegaly 2 (2.8%)
Splenomegaly 0
Skin and joints Arthritis Artalagia
Total
6 (16.7%
8 (22%)
14 (39%)
Erythema nodosum 3 (8.3%)
Perianal disease Anal fistula 6 (16.7%
Anal abscess 4 (11.1%
Anal ulcer 2 (5.6%)
Anal fissure 12 (33.3
Tags 8 (22.2%
Please cite this article in press as: Alreheili K, et al., Clinical presentat
experience), International Journal of Pediatrics and Adolescent MedicThe anatomic location of CD involvement at disease
presentation was categorized according to the 2005 Mon-
treal classification. Isolated terminal ileum involvement
(L1) was found in three patients (8.3%), and colon (L2) was
involved in 13 patients (36%). Ileocolic (L3) was the most
common site involved with 15 patients (41.6%). Small in-
testine involvement was recorded in 5 patients (13.9%) (see
Table 3). In UC, pancolitis was the most common finding
accounting for 74.1% of cases followed by left side colitis at
22.2%. Rectosigmoid was the lowest with 3.7% of cases (see
Table 3).
5. Discussion
Inflammatory bowel disease starts during childhood in
approximately 15%e25% of patients [17,18]. In our study,
we collected data from 66 patients over a 10 year period
with an average of 6e7 new cases per year. The incidence
of CD (54.5%) in our study exceeds that of UC (41%). This is
similar to what is reported in North America, Europe
[19e24] and also in recent local nationwide studies [5,7]. In
this study, male predominance was observed in both CD
(61%) and UC (56.6%). This predominance is also evident in
studies restricted to pediatric-onset CD, which document a
male to female preponderance [22e24]. In our study, UC
was higher among males, as it was in a nationwide study
[5], while it was equal for both sexes in many other inter-
national studies. This result is in contrast to the results of
similar studies conducted in nearby regions or other gulf
areas where females predominate males in the incidence of
UC [25,26].
Polito et al [28] reported that family history was higher
in patients under 20 years old than in older age groups,s in Saudi children.
UC IC Total (%)
%) 5 (18.5%) 2 (66.7%) 22 (33.3%)
%) 11 (40.7%) 2 (66.7%) 41 (62%)
27 (100%) 59 (89.4%)
%) 27 (100%) 1 (33.3%) 50 (75.8%)
%) 9 (33.3%) 34 (51.5%)
5 (18.5%) 3 (100%) 25 (37.9%)
%) 2 (7.4%) 14 (22.1%)
3 (11.1%) 8 (12.1%)
0 5 (7.6%)
2 (7.4%) 2 (3%)
2 (7.4%) 4 (6.1%)
1 (3.7%) 1 (1.5%)
) 1 (3.7%)
1 (3.7%)
2 (7.4%)
2 (66.7%)
2 (66.7%)
7 (10.6%)
9 (13.6%)
16 (24.2%)
0 3 (4.5%)
) 1 (3.7%) 7 (10.6%)
) 1 (3.7%) 5 (7.8%)
0 2 (3%)
%) 3 (11.1%) 15 (22.7%)
) 4 (14.8%) 12 (18.2%)
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56
Figure 1 Laboratory finding in IBD patient.
Table 3 Site of affection in CD and UC will be instead of
Figs. 2 and 3.Q11
CD UC
L1 (terminal ileum only) 8% Pancolitis 74%
L2 (colon only) 36% Left side colitis 22%
L3 (ileocolonic) 42% Rectosigmoid 4%
L3 (small intestine)
4 K. Alreheili et al.
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IJPAM87_proof ■ 15 September 2016 ■ 4/5which account for 30% of cases. In different studies pres-
ence of a family history varies between 11% and 29%
[24,27e32] This result was similar to our finding, where a
family history was reported in 19.7% of children with IBD.
This percentage was higher in UC patients for whom the
family history was found in 22.2% of patients.
The mean age at diagnosis for IBD was 8.1 y in our study
which was younger than previously reported [22e24]. This
finding may be observed because the age limit in our study
was 14 years, while it was 16 or 18 in other studies.
The most common presenting symptoms were abdominal
pain in patients with CD, bloody diarrhea in patients with
UC, and growth failure in patients with IC. Growth failure is
less striking in UC compared to CD and IC. These findings
were consisting with international IBD data. The classic
presentation of CD in any age group consists of a group of
symptoms, including abdominal pain, diarrhea, poor appe-
tite, and weight loss. This presentation comprises the mode
of presentation in nearly 80% of children and adolescents
[29], as it was in our patients. This result is in contrast to
the findings of a recent study in the UK, which showed that
this presentation was only reported in 25% of CD cases [23].
The clinical presentation of UC is considerably more
uniform than that of CD; bloody diarrhea is the almost
universal hallmark. Impairment of linear growth is rarely
present at diagnosis, partly because the presenting symp-
toms are more consistently obvious and therefore promptly
investigated [29]. This was demonstrated in our study as
well; while bloody diarrhea was the dominant presentation,
growth failure was found only in 18% of our patients.
The anatomic location of CD involvement at disease
presentation was categorized according to the 2005Please cite this article in press as: Alreheili K, et al., Clinical presentat
experience), International Journal of Pediatrics and Adolescent MedicMontreal classification. Classification of anatomic localiza-
tion will help clinicians to guide medical management
appropriately. In our study, ileocolic was the most
commonly affected site, which is similar to international
data in adult and pediatric cases. Small bowel involvement
was found in 13.9% of cases, which is similar to the rate
reported in several studies [31]. In UC, disease localization
did not differ from other pediatric populations, as pan-
colitis was the most common location, and rectosigmoid
was the least common location.
6. Conclusions
Our data regarding both CD and UC are similar to interna-
tional pediatric data. Although our center receives patients
from different regions of Saudi Arabia, a national pediatric
study is needed to provide more information and represent
the actual spectrum of this disease.
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